Charles River Laboratories has expanded its early discovery screening capabilities with access to Apricot Designs’ Dual Arm (ADDA) system for high-throughput absorption, distribution, metabolism, and excretion (HT-ADME) to identify potential lead compounds in North America and Europe. Charles River has also expanded its pharmacokinetic (PK) capabilities at sites in both San Francisco and Hertogenbosch, The Netherlands.   Early screening provides important insight into a compound’s underl...